IL-4 | Fold vs Control ± SE (n = 3) | |||
---|---|---|---|---|
Doses (nM) | ||||
1 | 10 | 100 | 1000 | |
Retinoid | ||||
ATRA | 1.7 ± 0.55 | 2.4 ± 0.40 | 2.5 ± 0.48 | 2.7 ± 0.64 |
9-cis-RA | 1.2 ± 0.05 | 2.3 ± 0.38 | 2.3 ± 0.57 | 2.4 ± 0.65 |
13-cis-RA | 1.2 ± 0.13 | 1.7 ± 0.25 | 1.7 ± 0.42 | 1.8 ± 0.30 |
4-HPR | 0.7 ± 0.11 | 0.8 ± 0.18 | 1.0 ± 0.13 | 1.6 ± 0.45 |
2-way ANOVA | ||||
Dose | p = 0.02 | |||
Retinoid | p = 0.0003 | |||
Tukey Kramer | ||||
Dose | p < 0.05 | 1 nM vs 100 nM | ||
1 nM vs 1000 nM | ||||
Retinoid | p < 0.01 | 4-HPR vs ATRA | ||
p < 0.01 | 4-HPR vs 9-cis-RA | |||
IL-5 | Fold vs Control ± SE (n = 3) | |||
Doses (nM) | ||||
1 | 10 | 100 | 1000 | |
Retinoid | ||||
ATRA | 1.9 ± 0.41 | 2.4 ± 1.0 | 2.8 ± 1.1 | 3.1 ± 1.3 |
9-cis-RA | 1.0 ± 0.10 | 2.4 ± 1.0 | 3.0 ± 0.85 | 3.0 ± 1.1 |
13-cis-RA | 1.3 ± 0.31 | 1.6 ± 0.45 | 1.9 ± 0.67 | 2.0 ± 0.84 |
4-HPR | 0.8 ± 0.05 | 0.9 ± 0.26 | 1.2 ± 0.40 | 1.5 ± 0.30 |
2-way ANOVA | ||||
Dose | p = 0.07 | |||
Retinoid | p = 0.005 | |||
Tukey Kramer | ||||
Retinoid | p < 0.05 | 4-HPR vs 9-cis RA | ||
p < 0.01 | 4-HPR vs ATRA |